IRON HYDROXIDE POLYMALTOSE 15mg. IP + FOLIC ACID 0.2mg. IP

An oral iron therapy for the treatment of any kind of iron deficiency such as the treatment of iron deficiency anemia and treatment of latent iron deficiency (depletion of iron stores). (Geisser, 2007) An anti-anemic medication that replenishes the iron stores in the body and treats iron and nutritional deficiency anemias. Corrects the iron deficiency with or without anemia in infants and small children. (Geisser, 2007) An effective agent in treating iron-deficiency anemia. (Geisser, 2007) Achieves a significant increase in Hb levels in children with iron deficiency anemia. (Beril Yasa, 2011) An oral iron replacement therapy in pediatric patients with iron deficiency anemia. (Beril Yasa, 2011) Displays a superior safety profile compared to ferrous sulfate for the treatment of iron-deficiency anemia. An advantageous formulation that exhibits greater tolerability and lower incidence of adverse effects compared to iron salts, such as ferrous sulfate. (José João Name, 2018)